OTC Medicines

CHPA President and CEO, Scott Melville, today released the following statement in response to the U.S. Food and Drug Administration’s announcement of a joint meeting between its Advisory Committees on Nonprescription Drugs and Obstetrics and Reproductive and Urologic Drugs.

Summary Excerpts from Select Federal Register Notices for CHPA Weekly Voice Week of August 29, 2022

Here are the Federal Register notice summary excerpts that might be of interest to you or others within your organization. Please see notices for complete details.

Consumer Healthcare Products Association (CHPA) President and CEO, Scott Melville, today released a statement in response to the National Academies of Sciences, Engineering, and Medicine’s report titled Review of Fate, Exposure, and Effects of Sunscreens in Aquatic Environments and Implications for Sunscreen Usage and Human Health.

Here are the Federal Register notice summary excerpts that might be of interest to you or others within your organization. Please see notices for complete details.

This past week, the House of Representatives adjourned for its annual August recess, although the House Democratic Leadership indicated that members would be called back sometime in August, should the Senate pass the Inflation Reduction Act of 2022.